UPDATED Jan 04, 2026
Discover French Pharmaceuticals & Biotech Growth Stocks that are on the CAC. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALCOX | €0.35 | 18.2% | 8.4% | €25.3m | €1.50 | PS8.5x | E179.3% | n/a | ||
AELIS | €1.13 | 0.4% | -43.8% | €15.8m | €11.00 | PS6.6x | E130.3% | n/a | ||
MEDCL | €23.90 | -4.4% | 31.3% | €791.2m | €35.10 | PS24.4x | E116.2% | n/a | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
ALERS | €24.10 | -1.6% | -4.7% | €243.1m | €30.00 | PE102.7x | E79.1% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
ALDVI | €1.84 | 4.4% | -6.4% | €26.0m | €3.50 | PS4.4x | E76.1% | n/a | ||
MAAT | €5.40 | 16.6% | -33.3% | €89.9m | €16.63 | PS22.2x | E63.5% | n/a | ||
EAPI | €2.16 | -1.1% | -28.1% | €205.3m | €2.96 | PB0.2x | E63.2% | n/a | ||
ABVX | €103.80 | -15.2% | 1,382.9% | €8.1b | €93.29 | PS1521.1x | E58.2% | n/a | ||
VLA | €3.77 | 0.5% | 64.8% | €655.1m | €6.35 | PS3.6x | E57.1% | n/a | ||
ADOC | €6.58 | 2.8% | 7.5% | €128.7m | €16.00 | PS10x | E56.0% | n/a | ||
IVA | €3.94 | 0.8% | 85.0% | €772.7m | €7.85 | PS44.4x | E54.5% | n/a | ||
DBV | €3.00 | -9.2% | 363.0% | €655.0m | €3.29 | PS127.8x | E53.2% | n/a | ||
ALSEN | €0.33 | -1.5% | -52.2% | €97.6m | €2.38 | PS17.3x | E42.4% | n/a | ||
ALOPM | €0.42 | 10.2% | -45.5% | €7.6m | €2.00 | PE1.2x | E41.5% | n/a | ||
NANO | €18.12 | -6.0% | 481.9% | €916.1m | €22.94 | PS86x | E38.1% | n/a | ||
GNFT | €5.18 | -2.1% | 43.3% | €257.9m | €8.57 | PS5.7x | E31.7% | n/a | ||
ALVAL | €0.68 | 0.4% | -55.3% | €16.2m | €2.20 | PS34.1x | E27.8% | n/a | ||
DIM | €214.40 | 3.3% | 11.2% | €20.9b | €241.46 | PE79x | E25.0% | 0.3% | ||
BOI | €30.40 | 0.7% | 13.2% | €522.6m | €25.00 | PE27.3x | E23.5% | 3.9% | ||
IPH | €1.56 | 1.3% | -16.4% | €144.2m | €4.90 | PS11.4x | E22.9% | n/a | ||
ERF | €67.14 | 8.1% | 35.2% | €11.9b | €66.20 | PE31.2x | E19.3% | 0.9% | ||
VIRP | €359.00 | 0.3% | 11.1% | €3.0b | €403.20 | PE22.6x | E11.4% | 0.4% |